Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Annals of Internal Medicine|March 13, 1999
Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study GroupK Malmstrom, G Rodriguez-Gomez, J Guerra, et al.
The Journal of Allergy and Clinical Immunology|September 1, 1996
Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthmaT F Reiss, L C Altman, P Chervinsky, et al.
The Journal of Pediatrics|September 17, 1998
Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthmaJ P Kemp, R J Dockhorn, G G Shapiro, et al.
Respiratory Medicine|March 3, 2009
Montelukast and bronchial inflammation in asthma: a randomised, double-blind placebo-controlled trialC F Ramsay, P Sullivan, M Gizycki, et al.
Thorax|March 18, 2000
Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patientsR J Dockhorn, R A Baumgartner, J A Leff, et al.
The Journal of Allergy and Clinical Immunology|May 16, 2000
Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trialE O Meltzer, K Malmstrom, S Lu, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|July 9, 2002
Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the springG Philip, K Malmstrom, F C Hampel, et al.
The European Respiratory Journal|September 18, 1999
Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trialE Pizzichini, J A Leff, T F Reiss, et al.
The American Review of Respiratory Disease|June 1, 1993
Acute bronchodilation with an intravenously administered leukotriene D4 antagonist, MK-679N Impens, T F Reiss, J A Teahan, et al.
Journal of Clinical Pharmacology|June 14, 2001
Montelukast dose selection in children ages 2 to 5 years: comparison of population pharmacokinetics between children and adultsB Knorr, H H Nguyen, G L Kearns, et al.
Pageof 5